Global MedTech CDMO M&A Update

The global MedTech CDMO industry in the first half of 2023 saw a sustained volume of M&A transactions, in line with H2 2022. We have compiled a list of implications of robust market activity indicating a continued high interest of global investors in MedTech CDMO despite a worsening economy and credit crunch.

Download this overview and discover:

• Key market insights and industry dynamics
• Deal activities and their implications
• Factors driving the growth and evolution